Effect of statin therapy on serum trace element status in dyslipidaemic subjects

Journal of Trace Elements in Medicine and Biology

Volumn 19, Issue 1 SPEC. ISS., 2005, Pages 61-67

  Ghayour Mobarhan, Majid ^a   Lamb, David J ^a   Taylor, Andrew ^a,b   Vaidya, Nandita ^b   Livingstone, Callum ^b   Wang, Timothy ^b   Ferns, Gordon A A ^a,b  

^a UNIVERSITY OF SURREY   (United Kingdom)

^b ROYAL SURREY COUNTY HOSPITAL   (United Kingdom)

Author keywords

C reactive protein; Copper; Selenium; Statins; Zinc

Indexed keywords

ATORVASTATIN; C REACTIVE PROTEIN; CERULOPLASMIN; COPPER; GLUTATHIONE PEROXIDASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SELENIUM; SIMVASTATIN; TRACE ELEMENT; ZINC;

ADULT; ANTIINFLAMMATORY ACTIVITY; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFECT; DYSLIPIDEMIA; FEMALE; HUMAN; INFLAMMATION; MALE; PRIORITY JOURNAL; REDUCTION;

EID: 24344482867     PISSN: 0946672X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtemb.2005.06.003     Document Type: Conference Paper

References (33)

1. J. Hippisley-Cox, R. Cater, M. Pringle, and C. Coupland Cross sectional survey of effectiveness of lipid lowering drugs in reducing serum cholesterol concentration in patients in 17 general practices Br Med J 326 2003 689 692
2. T.R. Pedersen, J. Kjekshus, and K. Berg Randomized trial of cholesterol-lowering in 4444 patients with coronary-heart-disease - the Scandinavian Simvastatin survival study (4S) Lancet 344 1994 1383 1389
3. J. Shepherd, S.M. Cobbe, and I. Ford Prevention of coronary heart-disease with pravastatin in men with hypercholesterolemia N Engl J Med 333 1995 1301 1307
4. R. Collins, J. Armitage, S. Parish, P. Sleight, and R. Peto MRC/BHF heart protection study of cholesterol-lowering with Simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial Lancet 361 2003 2005 2016
5. [Anon] Pleiotropic effects of statins may benefit cardiovascular system Can J Cardiol 14 1998 777
6. J. Davignon, and R. Laaksonen Low-density lipoprotein-independent effects of statins Curr Opin Lipidol 10 1999 543 559
7. G.K. Sukhova, J.K. Williams, and P. Libby Statins reduce inflammation in atheroma of nonhuman primates independent of effects on serum cholesterol Arterioscler Thromb Vasc Biol 22 2002 1452 1458
8. K. Shimizu, M. Aikawa, K. Takayama, P. Libby, and R.N. Mitchell Direct anti-inflammatory mechanisms contribute to attenuation of experimental allograft arteriosclerosis by statins Circulation 108 2003 2113 2120
9. G.A.A. Ferns Differential effects of statins on serum CRP levels: implications of recent clinical trials Atherosclerosis 169 2003 349 351
10. Y. Rikitake, S. Kawashima, and S. Takeshita Anti-oxidative properties of fluvastatin, an HMG-CoA reductase inhibitor, contribute to prevention of atherosclerosis in cholesterol-fed rabbits Atherosclerosis 154 2001 87 96
11. S. Wassmann, U. Laufs, and K. Muller Cellular antioxidant effects of atorvastatin in vitro and in vivo Arterioscler Thromb Vasc Biol 22 1902 300 305
12. G.A.A. Ferns, D.J. Lamb, and A. Taylor The possible role of copper ions in atherogenesis: the Blue Janus Atherosclerosis 133 1997 139 152
13. M.P. Rayman The importance of selenium to human health Lancet 356 2000 233 241
14. T.O. Fischmann, A. Hruza, and X.D. Niu Structural characterization of nitric oxide synthase isoforms reveals striking active-site conservation Nat Struct Biol 6 1999 233 242
15. K.M. Channon, H. Qian, and S.E. George Nitric oxide synthase in atherosclerosis and vascular injury - insights from experimental gene therapy Arterioscler Thromb Vasc Biol 20 2000 1873 1881
16. L.M. Klevay Dietary copper and risk of coronary heart disease Am J Clin Nutr 71 2000 1213 1214
17. S.M. Jethmalani, P. Murugaiyan, G. Viswanathan, and J.M. Noronha Plasma Copper and Zinc and their relationships with plasma-lipids, lipoproteins, lipase activity, and platelet-aggregation in hypertension and diabetes J Clin Biochem Nutr 9 1990 51 60
18. M. Manttari, V. Manninen, and J.K. Huttunen Serum ferritin and ceruloplasmin as coronary risk-factors Eur Heart J 15 1994 1599 1603
19. W.T. Friedwald, R.J. Levy, and D.S. Fredrickson Estimation of low density lipoprotein cholesterol in plasma without the use of preparative ultracentrifugation Clin Chim Acta 18 1972 499 502
20. A. Taylor Measurement of zinc in clinical samples Ann Clin Biochem 34 1997 142 150
21. N. Campillo, P. Vinas, I. Lopez-Garcia, and M. Hernandez-Cordoba Selenium determination in biological fluids using Zeeman background correction electrothermal atomic absorption spectrometry Anal Biochem 280 2000 195 200
22. D.E. Paglia, and W.N. Valentine Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase J Lab Clin Med 70 1967 158 169
23. F.W. Sunderman, and S. Nomoto Measurement of human serum caeruloplasmin by its p-phenylenediamine oxidase activity Clin Chem 16 1970 903 910
24. I. Jialal, D. Stein, D. Balis, S.M. Grundy, B. Adams-Huet, and S. Devaraj Effects of hydroxymethyl glutaryl coenzyme A reductase inhibitor therapy on high sensitivity C-reactive protein levels Circulation 103 2001 1933 1935
25. C. Pizzi, O. Manfrini, F. Fontana, and R. Bugiardini Angiotensin- converting enzyme inhibitors and 3-hydroxy-3-methylglutaryl coenzyme A reductase in cardiac syndrome X - role of superoxide dismutase activity Circulation 109 2004 53 58
26. B. Manuel-y-Keenoy, C. Van Campenhout, J. Vertommen, and I. De Leeuw Effects of atorvastatin on LDL sub-fractions and peroxidation in type 1 diabetic patients: a randomised double-blind placebo-controlled study Diabetes - Metab Res Rev 19 2003 478 486
27. W.A. Oranje, J.P.J.E. Sels, G.J.W.M. Rondas-Colbers, P.J.M.R. Lemmens, and B.H.R. Wolffenbuttel Effect of atorvastatin on LDL oxidation and antioxidants in normocholesterolemic type 2 diabetic patients Clin Chim Acta 311 2001 91 94
28. C. Abiaka, S. Olusi, and A. Al Awadhi Serum microminerals and the indices of lipid metabolism in an apparently healthy population J Clin Lab Anal 17 2003 61 65
29. B. Adam, S. Aslan, A. Bedir, and M. Alvur The interaction between copper and coronary risk indicators Jpn Heart J 42 2001 281 286
30. L.M. Klevay The influence of copper and zinc on the occurrence of ischemic-heart-disease J Environ Pathol Toxicol 4 1980 281 287
31. L.M. Klevay, W.G. Pond, and D.M. Medeiros Decreased high-density- lipoprotein cholesterol and apoprotein A-I in plasma and ultrastructural pathology in cardiac-muscle of young-pigs fed a diet high in zinc Nutr Res 14 1994 1227 1239
32. C.L. Tully, D.A. Snowdon, and J.D. Belcher Serum zinc and plasma lipoproteins in elderly women: findings from the nun study J Trace Elements Exp Med 8 1995 201 209
33. V. Juturu, R. Giri, M.M. Kesavulu, G. Subramanyam, and C.A. Rao Changes in serum zinc, sialic acid, glucose and lipid profile in NIDDM Trace Elements Electrolytes 16 1999 104 108